Insider trading

Period: 120 months Stock: OLMA Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

19 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

19 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

19 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

19 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
19 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
19 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

19 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will 2×
$606.35K 25,000 at 24.25
100%
Sold half or more
3 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will
$345.15K 15,000 at 23.01
100%
Sold half or more
23 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.75M 99,509 at 27.66
95.7%
Sold half or more
22 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.80M 100,000 at 28.04
64.9%
Sold half or more
19 Dec 2025
CLARK IAN T Director
Sold at will 3×
$7.87M 264,800 at 29.73
100%
Sold half or more
17 Dec 2024
Graham G. Walmsley Director · indirect
Sold at will
$4.73M 700,761 at 6.75
100%
Sold half or more
1 Aug 2024
Paradigm Biocapital Advisors LP 10% owner · indirect
Sold at will 2×
$35.80M 2,400,000 at 14.92
75.4%
Sold half or more
4 Jun 2024
Graham G. Walmsley Director · indirect
Sold at will 2×
$17.45M 1,175,000 at 14.85
62.6%
Sold half or more
10 Mar 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$24.95K 5,253 at 4.75
68.1%
Sold half or more
10 Jan 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$35.97K 5,251 at 6.85
68.1%
Sold half or more
10 Dec 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$54.56K 5,251 at 10.39
68.1%
Sold half or more
10 Nov 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$743.72K 27,668 at 26.88
93.9%
Sold half or more
11 Oct 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$146.51K 5,251 at 27.90
74.6%
Sold half or more
10 Sep 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$154.27K 5,251 at 29.38
74.6%
Sold half or more
10 Aug 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$134.98K 5,251 at 25.71
74.6%
Sold half or more
12 Jul 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$139.19K 5,251 at 26.51
74.6%
Sold half or more
10 Jun 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 3×
$156.07K 5,251 at 29.72
74.6%
Sold half or more
18 May 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$1.39M 57,763 at 24.15
97.0%
Sold half or more
19 Nov 2020
Bought 3×
$21.57M 1,135,334 at 19.00
50.3%
First buy on file
Showing 1–19 of 19.